We present six cases in a consecutive series of patients undergoing epikeratoplasty, in whom a therapeutic ptosis induced with botulinum toxin was given at the time of surgery. All patients achieved primary re-epitheli&-ition of their lyophilised grafts within 8 days or less, and no case of secondary epithelial breakdown was observed, nor any significant complication from the botulinum toxin. In patients with keratoconus and eye rubbing, epikeratoplasty may be the preferred method of surgical treatment because it does not compromise the integrity of the globe. An additional advantage of the procedure is that it is not associated with graft rejection problems,' which is particularly important for patients with mental handicap, Down's syndrome, and those who have poor compliance with treatment or follow up. However, graft failure in epikeratoplasty can occur through primary failure of re-epithelialisation of lyophilised graft tissue, or secondary epithelial breakdown.' If epithelial defects are persistent, the lyophilised graft will suffer from stromal melting, and so the standard postoperative management includes close follow up, frequent application of topical ointment, and the use of bandage contact lenses, patching, etc. In patients with poor compliance, therapeutic ptosis induced by botulinum toxin could be a useful adjunct in the management of epikeratoplasty grafts, as it has been shown to be an effective treatment of epithelial defects in disease states.' Therapeutic prosis with botulinum toxin in epikeratoplasty 
Case reports
A series of six cases of keratoconus managed by epikeratoplasty combined with botulinum toxin induced ptosis is summarised in Table 1 , and illustrated in Figure 1 .
All the patients were treated with lyophilised lenticules (Keratec Eye Bank, London) prepared from desiccated corneal tissue lathed at room temperature.The lenticules were plano powered and 9 mm in diameter, sutured into an 8.5 mm bed with multiple interrupted 1110 mersilene.
The ptosis was obtained by making up 500 units of botulinum toxin A with 2.5 m1 of saline (Porton International) and injecting 0.1 m1 (20 units) into the levator palpebrae superioris muscle at the beginning of surgery. Kirkness et a1 used 62.5 pg of toxin (equivalent to 3 units) to induce ptosis, but had a higher rate of failure and repeat injections.
In three of the cases a 610 prolene tarsorrhaphy suture tied over a bolster was used to close the eyelids temporarily while the onset of the ptosis was awaited -usually 1-3 days. In the other three patients a collagen bandage lens was used as an alternative to give cover during this period, but was not retained in the uncooperative patients (cases 3 and 4).
Comment
The exact time to complete re-epithelialisation was not known in cases 1 4 , since they were all discharged following surgery and returned after 7 days for examination under anaesthesia. Case 5 was similarly discharged. following surgery and reviewed as an outpatient on day 8. However, case 6 was managed as an inpatient, and examination of the graft surface by manually assisted opening of the eyelids at the medial canthus showed full re-epithelialisation on day 3, at which time the tarsorrhaphy suture was removed. The ptosis persisted in all cases for a minimum of 6 weeks, and during this period the epithelium stabilised on the graft and there were no instances of secondary epithelia1 breakdown.
